328 related articles for article (PubMed ID: 11676820)
1. Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis.
Schmuth M; Yosipovitch G; Williams ML; Weber F; Hintner H; Ortiz-Urda S; Rappersberger K; Crumrine D; Feingold KR; Elias PM
J Invest Dermatol; 2001 Oct; 117(4):837-47. PubMed ID: 11676820
[TBL] [Abstract][Full Text] [Related]
2. Impaired cutaneous permeability barrier function, skin hydration, and sphingomyelinase activity in keratin 10 deficient mice.
Jensen JM; Schütze S; Neumann C; Proksch E
J Invest Dermatol; 2000 Oct; 115(4):708-13. PubMed ID: 10998148
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis).
Schmuth M; Fluhr JW; Crumrine DC; Uchida Y; Hachem JP; Behne M; Moskowitz DG; Christiano AM; Feingold KR; Elias PM
J Invest Dermatol; 2004 Apr; 122(4):909-22. PubMed ID: 15102081
[TBL] [Abstract][Full Text] [Related]
4. Normal ultrastructure, but altered stratum corneum lipid and protein composition in a mouse model for epidermolytic hyperkeratosis.
Reichelt J; Doering T; Schnetz E; Fartasch M; Sandhoff K; Magin AM
J Invest Dermatol; 1999 Sep; 113(3):329-34. PubMed ID: 10469329
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
Menon GK; Feingold KR; Mao-Qiang M; Schaude M; Elias PM
J Invest Dermatol; 1992 Feb; 98(2):209-19. PubMed ID: 1732385
[TBL] [Abstract][Full Text] [Related]
6. Basis for the permeability barrier abnormality in lamellar ichthyosis.
Elias PM; Schmuth M; Uchida Y; Rice RH; Behne M; Crumrine D; Feingold KR; Holleran WM; Pharm D
Exp Dermatol; 2002 Jun; 11(3):248-56. PubMed ID: 12102664
[TBL] [Abstract][Full Text] [Related]
7. Ontogeny of the epidermal barrier to water loss in the rat: correlation of function with stratum corneum structure and lipid content.
Aszterbaum M; Menon GK; Feingold KR; Williams ML
Pediatr Res; 1992 Apr; 31(4 Pt 1):308-17. PubMed ID: 1570196
[TBL] [Abstract][Full Text] [Related]
8. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function.
Behne M; Uchida Y; Seki T; de Montellano PO; Elias PM; Holleran WM
J Invest Dermatol; 2000 Jan; 114(1):185-92. PubMed ID: 10620136
[TBL] [Abstract][Full Text] [Related]
9. Filaggrin expression in epidermolytic ichthyosis (epidermolytic hyperkeratosis).
Ishida-Yamamoto A; Eady RA; Underwood RA; Dale BA; Holbrook KA
Br J Dermatol; 1994 Dec; 131(6):767-79. PubMed ID: 7531997
[TBL] [Abstract][Full Text] [Related]
10. Altered distribution of keratinization markers in epidermolytic hyperkeratosis.
Ishida-Yamamoto A; Iizuka H; Manabe M; O'Guin WM; Hohl D; Kartasova T; Kuroki T; Roop DR; Eady RA
Arch Dermatol Res; 1995; 287(8):705-11. PubMed ID: 8554380
[TBL] [Abstract][Full Text] [Related]
11. Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2.
Demerjian M; Hachem JP; Tschachler E; Denecker G; Declercq W; Vandenabeele P; Mauro T; Hupe M; Crumrine D; Roelandt T; Houben E; Elias PM; Feingold KR
Am J Pathol; 2008 Jan; 172(1):86-97. PubMed ID: 18156206
[TBL] [Abstract][Full Text] [Related]
12. Mild recessive epidermolytic hyperkeratosis associated with a novel keratin 10 donor splice-site mutation in a family of Norfolk terrier dogs.
Credille KM; Barnhart KF; Minor JS; Dunstan RW
Br J Dermatol; 2005 Jul; 153(1):51-8. PubMed ID: 16029326
[TBL] [Abstract][Full Text] [Related]
13. Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.
Rizzo WB; S'Aulis D; Jennings MA; Crumrine DA; Williams ML; Elias PM
Arch Dermatol Res; 2010 Aug; 302(6):443-51. PubMed ID: 20049467
[TBL] [Abstract][Full Text] [Related]
14. Vitamin C enhances differentiation of a continuous keratinocyte cell line (REK) into epidermis with normal stratum corneum ultrastructure and functional permeability barrier.
Pasonen-Seppänen S; Suhonen TM; Kirjavainen M; Suihko E; Urtti A; Miettinen M; Hyttinen M; Tammi M; Tammi R
Histochem Cell Biol; 2001 Oct; 116(4):287-97. PubMed ID: 11702187
[TBL] [Abstract][Full Text] [Related]
15. Barrier function of the skin: "la raison d'être" of the epidermis.
Madison KC
J Invest Dermatol; 2003 Aug; 121(2):231-41. PubMed ID: 12880413
[TBL] [Abstract][Full Text] [Related]
16. Epidermolytic hyperkeratosis.
Bale SJ; Compton JG; DiGiovanna JJ
Semin Dermatol; 1993 Sep; 12(3):202-9. PubMed ID: 7692917
[TBL] [Abstract][Full Text] [Related]
17. Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1.
Kuramoto N; Takizawa T; Takizawa T; Matsuki M; Morioka H; Robinson JM; Yamanishi K
J Clin Invest; 2002 Jan; 109(2):243-50. PubMed ID: 11805136
[TBL] [Abstract][Full Text] [Related]
18. Stratum corneum hydration and flexibility are useful parameters to indicate clinical severity of congenital ichthyosis.
Tomita Y; Akiyama M; Shimizu H
Exp Dermatol; 2005 Aug; 14(8):619-24. PubMed ID: 16026584
[TBL] [Abstract][Full Text] [Related]
19. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model.
Ghadially R; Brown BE; Sequeira-Martin SM; Feingold KR; Elias PM
J Clin Invest; 1995 May; 95(5):2281-90. PubMed ID: 7738193
[TBL] [Abstract][Full Text] [Related]
20. Abrupt decreases in environmental humidity induce abnormalities in permeability barrier homeostasis.
Sato J; Denda M; Chang S; Elias PM; Feingold KR
J Invest Dermatol; 2002 Oct; 119(4):900-4. PubMed ID: 12406336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
